Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆
Titel:
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆
Auteur:
Casali, P.G. Le Cesne, A. Velasco, A.P. Kotasek, D. Rutkowski, P. Hohenberger, P. Fumagalli, E. Judson, I.R. Italiano, A. Gelderblom, H. Penel, N. Hartmann, J.T. Duffaud, F. Goldstein, D. Martin-Broto, J. Gronchi, A. Wardelmann, E. Marréaud, S. Zalcberg, J.R. Litière, S. Blay, J.-Y.